Bluejay Therapeutics Funding & Investors
San Francisco, CA
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases. The company’s first target indication is chronic Hepatitis B, which remains a worldwide prevalent disease with urgent unmet medical need. Bluejay is advancing two innovative appro... Read more
bluejaytx.comTotal Amount Raised: $242,239,984
Bluejay Therapeutics Funding Rounds
Series C
$182,000,000
Series C Investors
Frazier Life SciencesWellington ManagementHBM Healthcare InvestmentsUnicorn Capital PartnersOctagon Capital AdvisorsNovo HoldingsRiverVest Venture ManagementT. Rowe PriceRa Capital ManagementArkin Bio VenturesSeries B
$41,000,000
Series B Investors
Arkin Bio VenturesYonjin VentureRiverVest Venture ManagementOctagon Capital AdvisorsSynergenicsSeries Unknown
$19,239,990
Funding info provided by Diffbot.